Kaya Holdings (KAYS) Income from Non-Controlling Interests (2022 - 2023)
Kaya Holdings (KAYS) recorded quarterly Income from Non-Controlling Interests of -$32226.0 in Q1 2023, down 33.58% quarter-over-quarter from -$24124.0 in Q1 2022, and down 33.58% on a YoY basis from -$48522.0 in Q1 2022.
Kaya Holdings (KAYS) Income from Non-Controlling Interests (2022 - 2023) Analysis & Trends
Kaya Holdings' Income from Non-Controlling Interests history runs 2 years deep, the most recent figure standing at -$32226.0 for Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 22.56 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Kaya Holdings | - | - | 5,370.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -32,226.00 |
| Mar 31, 2022 | -24,124.00 |